American Century Companies’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-79,349
| Closed | -$220K | – | 2913 |
|
|
2024
Q4 | $220K | Buy |
79,349
+8,263
| +12% | +$22.9K | ﹤0.01% | 2767 |
|
|
2024
Q3 | $372K | Buy |
71,086
+13,986
| +24% | +$73.1K | ﹤0.01% | 2571 |
|
|
2024
Q2 | $255K | Buy |
57,100
+5,673
| +11% | +$25.3K | ﹤0.01% | 2680 |
|
|
2024
Q1 | $394K | Buy |
51,427
+22,732
| +79% | +$174K | ﹤0.01% | 2531 |
|
|
2023
Q4 | $122K | Buy |
28,695
+10,622
| +59% | +$45.3K | ﹤0.01% | 2790 |
|
|
2023
Q3 | $75.9K | Buy |
18,073
+5,873
| +48% | +$24.7K | ﹤0.01% | 2758 |
|
|
2023
Q2 | $68K | Buy |
+12,200
| New | +$68K | ﹤0.01% | 2738 |
|